Navigating the Landscape of B Cell Mediated Immunity and Antibody Monitoring in SARS-CoV-2 Vaccine Efficacy: Tools, Strategies and Clinical Trial Insights
Open Access
Abstract
Correlates of Protection (CoP) are biomarkers above a defined threshold that can replace clinical outcomes as primary endpoints, predicting vaccine effectiveness to support the approval of new vaccines or follow up studies. In the context of COVID-19 vaccination, CoPs can help address challenges such as demonstrating vaccine effectiveness in special populations, against emerging SARS-CoV-2 variants or determining the durability of vaccine-elicited immunity. While anti-spike IgG titres and viral neutralising capacity have been characterised as CoPs for COVID-19 vaccination, the contribution of other components of the humoral immune response to immediate and long-term protective immunity is less well characterised. This review examines the evidence supporting the use of CoPs in COVID-19 clinical vaccine trials, and how they can be used to define a protective threshold of immunity. It also highlights alternative humoral immune biomarkers, including Fc effector function, mucosal immunity, and the generation of long-lived plasma and memory B cells and discuss how these can be applied to clinical studies and the tools available to study them.Keywords
Funding Information
- Science Foundation Ireland (20/COV/0305, GOIPG/2019/4432)
- Irish Research Council (20/COV/0305, GOIPG/2019/4432)
This publication has 214 references indexed in Scilit:
- Antibody Fc-binding profiles and ACE2 affinity to SARS-CoV-2 RBD variantsMedical Microbiology and Immunology, 2023
- Regenerable and high-throughput surface plasmon resonance assay for rapid screening of anti-SARS-CoV-2 antibody in serum samplesAnalytica Chimica Acta, 2022
- Validation and performance of a multiplex serology assay to quantify antibody responses following SARS‐CoV‐2 infection or vaccinationClinical & Translational Immunology, 2022
- Recognition of the SARS-CoV-2 receptor binding domain by neutralizing antibodiesBiochemical and Biophysical Research Communications, 2021
- Development of a Rapid Focus Reduction Neutralization Test Assay for Measuring SARS‐CoV‐2 Neutralizing AntibodiesCurrent Protocols in Immunology, 2020
- Compromised Humoral Functional Evolution Tracks with SARS-CoV-2 MortalityCell, 2020
- Evaluation of SARS‐CoV‐2 neutralizing antibodies using a CPE‐based colorimetric live virus micro‐neutralization assay in human serum samplesJournal of Medical Virology, 2020
- Chemiluminescent immunoassay technology: what does it change in autoantibody detection?Autoimmunity Highlights, 2017
- Surface plasmon resonance imaging analysis of protein–protein interactions using on-chip-expressed capture proteinAnalytical Biochemistry, 2006
- A solid-phase enzyme-linked immunospot (ELISPOT) assay for enumeration of specific antibody-secreting cellsJournal of Immunological Methods, 1983